We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.15B
AUM Growth
-$677M
Cap. Flow
-$723M
Cap. Flow %
-11.75%
Top 10 Hldgs %
23.02%
Holding
3,299
New
49
Increased
1,172
Reduced
1,878
Closed
60

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$56.7M
2
MSFT icon
Microsoft
MSFT
+$52.5M
3
FERG icon
Ferguson
FERG
+$49.5M
4
ROK icon
Rockwell Automation
ROK
+$44.2M
5
BAH icon
Booz Allen Hamilton
BAH
+$41M

Sector Composition

Rank Sector Weight
1 Technology 24.96%
2 Financials 15.32%
3 Industrials 10.98%
4 Consumer Discretionary 8.91%
5 Healthcare 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVEX icon
2951
Eve Holding
EVEX
$990M
$2.5K ﹤0.01%
626
+502
+405% +$2.21K
STKL
2952
DELISTED
SunOpta
STKL
$2.5K ﹤0.01%
657
+425
+183% +$1.93K
VUZI icon
2953
Vuzix
VUZI
$217M
$2.48K ﹤0.01%
655
+247
+61% +$776
CERS icon
2954
Cerus
CERS
$508M
$2.47K ﹤0.01%
1,201
+754
+169% +$1.31K
COOK icon
2955
Traeger
COOK
$172M
$2.45K ﹤0.01%
45
CLPT icon
2956
ClearPoint Neuro
CLPT
$444M
$2.42K ﹤0.01%
177
+113
+177% +$2.1K
NPCE icon
2957
Neuropace
NPCE
$507M
$2.41K ﹤0.01%
156
+98
+169% +$1.31K
CDXS icon
2958
Codexis
CDXS
$161M
$2.4K ﹤0.01%
1,471
+273
+23% +$557
GOGO icon
2959
Gogo Inc
GOGO
$432M
$2.39K ﹤0.01%
513
+326
+174% +$2.39K
DRUG
2960
Bright Minds Biosciences
DRUG
$793M
$2.34K ﹤0.01%
30
+19
+173% +$1.27K
FEIM icon
2961
Frequency Electronics
FEIM
$801M
$2.31K ﹤0.01%
43
+27
+169% +$993
ORGO icon
2962
Organogenesis Holdings
ORGO
$239M
$2.3K ﹤0.01%
444
+279
+169% +$1.35K
CURV icon
2963
Torrid Holdings
CURV
$249M
$2.28K ﹤0.01%
2,328
ABEO icon
2964
Abeona Therapeutics
ABEO
$425M
$2.25K ﹤0.01%
427
+169
+66% +$851
BVS icon
2965
Bioventus
BVS
$1.17B
$2.23K ﹤0.01%
300
+188
+168% +$1.35K
CTEV
2966
Claritev Corp
CTEV
$581M
$2.22K ﹤0.01%
52
+34
+189% +$1.73K
CARL
2967
Carlsmed
CARL
$375M
$2.21K ﹤0.01%
179
+19
+12% +$253
NGVC icon
2968
Vitamin Cottage Natural Grocers
NGVC
$605M
$2.2K ﹤0.01%
88
+57
+184% +$1.82K
SVCO
2969
Silvaco Group
SVCO
$247M
$2.19K ﹤0.01%
541
LTBR icon
2970
Lightbridge
LTBR
$292M
$2.17K ﹤0.01%
172
+121
+237% +$2.33K
NAGE
2971
Niagen Bioscience
NAGE
$241M
$2.16K ﹤0.01%
339
+213
+169% +$1.48K
KRUS icon
2972
Kura Sushi USA
KRUS
$590M
$2.15K ﹤0.01%
41
+26
+173% +$1.42K
SGHT icon
2973
Sight Sciences
SGHT
$424M
$2.13K ﹤0.01%
269
+169
+169% +$1.08K
IBTA icon
2974
Ibotta
IBTA
$729M
$2.07K ﹤0.01%
91
+57
+168% +$1.54K
NVEC icon
2975
NVE Corp
NVEC
$573M
$2.02K ﹤0.01%
34
+22
+183% +$1.47K

Similar funds

Sterling Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Sterling Capital Management held 3,299 positions worth $6.15B, down 9.9% from $6.83B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $723M in Q4 2025, closing 60 positions and reducing 1,878 holdings. Its most notable exit was Kellanova, an estimated $1.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

Against the trend, Sterling Capital Management opened a new position in abrdn Emerging Markets Dividend Active ETF worth $24.1M.

  • Sterling Capital Management's largest Q4 2025 buy was abrdn Emerging Markets Dividend Active ETF: 629,063 shares worth $24.1M.
  • Sterling Capital Management added most to Southern Company in Q4 2025, an estimated $44.8M increase.
  • Sterling Capital Management's biggest Q4 2025 reduction was Analog Devices, cutting an estimated $56.7M.
  • Sterling Capital Management fully exited Kellanova in Q4 2025, selling an estimated $1.41M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $6.15B portfolio in Q4 2025.
  • Sterling Capital Management opened 49 new positions and closed 60 in Q4 2025.
  • Sterling Capital Management's portfolio value fell 9.9% quarter-over-quarter to $6.15B.

Based on Sterling Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.